Veraxa Biotech AG (VRXA) Live Share Price, Invest From India

Veraxa Biotech AG Stock Performance

as on August 12, 2026 at 4:08 am IST

Day's Low
Day's High
$1.82
Day's Price Range
$1.94
$1.91
4.71%
Downside
1.57%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$1.91
100.00%
Downside
-100.00%
Upside

Veraxa Biotech AG share price movements today

Previous Close: $1.85
Open: $1.82
Volume: 126.9K
Day's Low - High: $1.82 - $1.94

Veraxa Biotech AG Historical Returns

1 Month Return: -15.91 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Veraxa Biotech AG Stock Fundamentals & Key Indicators

Check Veraxa Biotech AG market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$281.4M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

0.00%

Veraxa Biotech AG vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Veraxa Biotech AG with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Veraxa Biotech AG	NA	$281.4M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$44.0B	669.41%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$125.7B	168.33%	28.91	35.00%	NA
Regeneron Pharmaceuticals Inc.	BUY	$80.8B	32.8%	19.42	27.87%	0.47000000000000003%

Indian Investors' Interest in Veraxa Biotech AG Stock

Search interest for Veraxa Biotech AG Stock has decreased by -60% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 12, 2026 to August 11, 2026

Change:-60% versus previous 30 day period

Veraxa Biotech AG Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	0
Gross Profit	-	-	0
Operating Income	-16	-28	-66
EBITDA	-	-	-
Interest Expense	0	0	0
Depreciation	1	1	1
Income Before Tax	-17	-28	-67
Income Tax Expense	-	-	-
Net Income	-19	-31	-66
Net Profit Margin	0.00%	0.00%	-284359.22%

Veraxa Biotech AG Annual Cash Flow

All numbers in Millions USD

	Dec 2024	Dec 2025
Net Income	-28	-66
Operating Cash Flow	-7	-9
Investing Cash Flow	-	-
Financing Cash Flow	1	6
Change in Cash	-5	-3

Insights on Veraxa Biotech AG

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 496.5% return, outperforming this stock by 578.7%
NEGATIVE IMPACT
Price Dip
In the last 3 months, VRXA stock has moved down by -83.0%

About Veraxa Biotech AG

VERAXA Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, including antibody-drug conjugates and bispecific antibody formats, and offers a proprietary technology platform for functional antibody screening and bioconjugation. Its product pipeline includes drug candidates such as ADCs and BITACs, with some in clinical development, and it provides partnership models for collaborative development from target identification to antibody and ADC creation. The company utilizes proprietary payloads and genetic code expansion technology to engineer and manufacture homogeneous, stable bioconjugates with defined drug-to-antibody ratios. It also licenses technology platforms to support the development of new therapeutic strategies. The company serves professional clients in the healthcare sector, including those in drug development, biologicals, diagnostics, instrumentation, and partners with research organizations and business partners in the life sciences industry. The company was founded in 2021 and is based in Heidelberg, Germany.

Organisation	Veraxa Biotech AG
Headquarters	Im Neuenheimer Feld 584, Heidelberg, Germany, 69120
Industry	Biotechnology
CEO	Dr. Christoph Antz Ph.D.
E-voting on shares	Click here to vote

Key Management of Veraxa Biotech AG

Name	Title
Dr. Christoph Antz Ph.D.	Co-Founder, Lead Director & CEO
Mr. Carl von Halem	Interim CFO, Principal Financial Officer & Principal Accounting Officer
Dr. Christoph Erkel Ph.D.	Chief Scientific Officer
Dr. Heinz Schwer M.B.A., Ph.D.	Chief Business Officer

FAQs

What is Veraxa Biotech AG share price today?

Veraxa Biotech AG share price today is $1.91 as on August 11, 2026 at 10:38 pm IST. Veraxa Biotech AG share today touched a day high of $1.94 and a low of $1.82.

What is the 52 week high and 52 week low for Veraxa Biotech AG share?

Veraxa Biotech AG share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Veraxa Biotech AG stock price today i.e. August 11, 2026 at 10:38 pm IST is trending at $1.91,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Veraxa Biotech AG's market capitalisation today?

Veraxa Biotech AG market capitalisation is $0.00T as on August 11, 2026 at 10:38 pm IST.

How to invest in Veraxa Biotech AG Stock (VRXA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Veraxa Biotech AG on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Veraxa Biotech AG Shares that will get you 0.7853 shares as per Veraxa Biotech AG share price of $1.91 per share as on August 11, 2026 at 10:38 pm IST.

What is the minimum amount required to buy Veraxa Biotech AG Stock (VRXA) from India?

Indian investors can start investing in Veraxa Biotech AG (VRXA) shares with as little as ₹95.435 or $1 (as of August 11, 2026 at 10:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹954.35 in Veraxa Biotech AG stock (as per the Rupee-Dollar exchange rate as on August 11, 2026 at 10:42 pm IST). Based on Veraxa Biotech AG share’s latest price of $1.91 as on August 11, 2026 at 10:38 pm IST, you will get 5.2356 shares of Veraxa Biotech AG. Learn more about fractional shares .